[
    [
        {
            "time": "",
            "original_text": "民生医药|周报】外包行业3/9：持续推荐CXO板块具备α属性的公司",
            "features": {
                "keywords": [
                    "民生医药",
                    "外包行业",
                    "CXO板块",
                    "α属性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "民生医药|周报】外包行业3/9：持续推荐CXO板块具备α属性的公司",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "国金策略：哪些个股被“外资化”了？（附股）",
            "features": {
                "keywords": [
                    "国金策略",
                    "外资化",
                    "个股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国金策略：哪些个股被“外资化”了？（附股）",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国内医药CRO行业高速发展，具备技术优势企业或迎更大红利",
            "features": {
                "keywords": [
                    "医药CRO",
                    "高速发展",
                    "技术优势",
                    "红利"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国内医药CRO行业高速发展，具备技术优势企业或迎更大红利",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【东吴医药】泰格医药2019年业绩快报点评：非经常损益会计准则变化，扣非后净利润同比增长53.5%，公司业绩符合预期",
            "features": {
                "keywords": [
                    "东吴医药",
                    "泰格医药",
                    "业绩快报",
                    "非经常损益",
                    "会计准则",
                    "扣非后净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【东吴医药】泰格医药2019年业绩快报点评：非经常损益会计准则变化，扣非后净利润同比增长53.5%，公司业绩符合预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]